tirzepatide bcbs coverage CVS Caremark drops Zepbound for Wegovy for weight loss – Boston 25 News Rising Costs Lead Insurers to

Reframe has helped eliminate over 300,000 drinks per month, demonstrating the tangible impact of technology-driven support systems

The case settled in March 2026: Novo dropped the lawsuit in exchange for Hims agreeing to transition its platform entirely to authorized, branded semaglutide products and to cease all advertising of compounded GLP-1 alternatives

Mller TD, Finan B, Bloom SR, DAlessio D, Drucker DJ, et al

Furthermore, the weight loss effect of semaglutide was far greater than comparators (who either receive a placebo or other GLP-1 agonists) regardless of basal BMI[1]

When discussing alternatives with your GP, be open about: Your experience with Rybelsus, including both benefits and difficulties Your treatment priorities (glucose control, weight management, convenience, side effect profile) Any concerns about injections if considering injectable GLP-1 agonists Your ability to adhere to different dosing schedules Non-pharmacological approaches remain fundamental to diabetes management regardless of medication choice

If your real goal is to drink less, you do not have to wait for the research to catch up